NEW YORK, May 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Viatris Inc. (NASDAQ: VTRS).Shareholders who purchased shares of VTRS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/viatris-inc-loss-submission-form-2/?id=148823&from=4CLASS PERIOD: August 8, 2024 to February ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Viatris Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on June 3, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Viatris securities between August 8, 2024, and February 26, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by June 3, 2025 [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3]. Group 3: Case Background - The lawsuit alleges that during the Class Period, Viatris provided misleading information regarding the failed inspection of its Indore, India facility, including the issuance of an FDA warning letter that impacted the shipment of eleven products [4]. - Defendants allegedly downplayed the significance of the warning letter, referring to it as a "minor headwind," while failing to disclose critical details about the inspection, remediation efforts, and the financial implications for Viatris [5].

NEW YORK, May 17, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Viatris, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/viatris-inc. Investors have until June 3, 2025, to ask the Court to be appointed to lead the case. ...

Core Viewpoint - A class action securities lawsuit has been filed against Viatris Inc. due to alleged securities fraud impacting investors between August 8, 2024, and February 26, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Viatris misrepresented the implications of a warning letter from the FDA regarding its Indore, India facility, downplaying its significance as a "minor headwind" [2] - Following the announcement of disappointing financial results for Q4 and fiscal year 2024 on February 27, 2025, Viatris' stock price dropped from $11.24 to $9.53, a decline of approximately 15.21% in one day [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation does not require this role [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions for shareholders and is recognized as one of the top securities litigation firms in the U.S. [4]

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Viatris Inc. (NASDAQ: VTRS). Shareholders who purchased shares of VTRS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/viatris-inc-loss-submission-form-2/?id=148457&from=3 CLASS PERIOD: August 8, 2024 to F ...

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Viatris, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/viatris-inc. Investors have until June 3, 2025, to ask the Court to be appointed to lead the case. ...

NEW YORK, May 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Viatris Inc. (NASDAQ: VTRS).Shareholders who purchased shares of VTRS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/viatris-inc-loss-submission-form-2/?id=148432&from=4CLASS PERIOD: August 8, 2024 to February ...

Viatris Inc. (NASDAQ:VTRS) BofA Securities 2025 Healthcare Conference May 13, 2025 8:00 PM ET Company Participants Doretta Mistras - CFO Philippe Martin - Chief R&D Officer Conference Call Participants Jason Gerberry - BofA Securities Jason Gerberry Keep going here at the BofA Annual Healthcare Conference, and our last company presenter of the day, Viatris. Joining us is Doretta Mistras, Chief Financial Officer; and Philippe Martin, Chief R&D Officer. Martin or Martin? Philippe Martin Whatever you want. Mar ...

Core Viewpoint - Viatris Inc. is facing a securities class action lawsuit due to allegations of failing to disclose material information during the specified class period, leading to significant investor losses [4]. Group 1: Lawsuit Details - Investors who incurred losses exceeding $100,000 from purchasing Viatris securities between August 8, 2024, and February 26, 2025, have until June 3, 2025, to file lead plaintiff applications [1]. - The lawsuit is pending in the United States District Court for the Western District of Pennsylvania, with the case titled Quinn v. Viatris Inc., et al., No. 25-cv-466 [5]. - Viatris announced disappointing fiscal 2025 guidance on February 27, 2025, attributing the decline to issues related to the Indore facility, which caused the stock price to drop from $11.24 to $9.53 per share [5]. Group 2: Legal Representation - Kahn Swick & Foti, LLC (KSF) is representing investors in this class action, and they are recognized as one of the top boutique securities litigation law firms in the nation [6]. - Investors may choose to serve as lead plaintiffs, allowing them to select lead counsel, direct litigation, and participate in settlement discussions [2]. Group 3: Company Background - Viatris is a publicly traded company that has faced scrutiny for its disclosure practices, which are now under legal examination due to the recent allegations [4]. - KSF has a history of serving various clients, including institutional and retail investors, in recovering losses from corporate fraud or malfeasance [6].

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Viatris investors who were adversely affected by alleged securities fraud between August 8, 2024 and February 26, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission- ...